SW756 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Reproductive system cancer cell lines

Organism

Human

Donor History

Squamous cell carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium + 10% DMSO for adequate post-thaw viability. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/SW756-Cells/305588

SKU: 305588 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

SW756 is a human cervical carcinoma cell line derived from a primary squamous cell carcinoma of the cervix in an adult female. It was included in early comprehensive cell line characterization efforts and has been validated as free from HeLa contamination based on glucose-6-phosphate dehydrogenase (G6PD) isoenzyme typing, which confirmed it to be type B, unlike HeLa cells, which are type A. This ensures its authenticity as a distinct cervical cancer model.

SW756 is classified as a squamous cell carcinoma and has been used in various genomic and proteomic profiling studies, including large-scale pharmacogenomic and functional genomics datasets. In proteomic profiling efforts such as the ProCan-DepMapSanger dataset, SW756 contributes to a broader understanding of protein expression regulation, particularly in relation to post-transcriptional modifications and drug response correlations. Such datasets have shown that proteomic data from SW756, like other cell lines, can reveal patterns of lineage-specific expression and regulatory mechanisms that are not always evident at the transcriptomic level, highlighting its utility in integrated multi-omic analyses.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.